retatrutide covered by insurance How To Get with a Clinical Trial Patients seeking retatrutide outside of

Retatrutide could become the first obesity therapy to carry a secondary indication for liver fat management, which would dramatically expand its clinical relevance beyond weight loss alone

Weight loss efficacy The STEP trial showed that semaglutide produced an average 15% body weight loss over 68 weeks

Still, like many side effects, it can be minimized by starting with a lower dose and gradually increasing it, as your healthcare provider recommends

GLP-1 GLP-1 is a peptide hormone generated through the enzymatic breakdown of proglucagon

For this reason, retatrutide may help people who have insulin resistance or obesity